| Notice Filed with SOS |
10/15/2020 |
| Rule |
ProposedRuleAttach2020-00821.doc |
| Statutory Authority |
Sections 12-20-204(1), 12-280-101, 12-280-107, and 24-4-103, C.R.S. |
| Description of Subjects/Issues |
The purpose of this Permanent Rulemaking Hearing is for the Board to consider adopting a new rule to implementation of Colorado Senate Bill 20-102 (Concerning the Requirement of Providers to provide Disclosure of Sexual Misconduct to Patients prior to Treatment), and revisions to Rule 17.00.00, as required by the Office of Legislative Legal Services (OLLS). |
| Purpose/Objective of Rule |
The State Board of Pharmacy adopted a new rule to implement Colorado Senate Bill 20-102 (Concerning the Requirement of Providers to provide Disclosure of Sexual Misconduct to Patients prior to Treatment). |
| Submitted in response to issues raised by COLS/OLLS? |
No
|
| Is this rule adopted in response to recent legislation? |
Yes
|
| Recent legislation bill number |
SB20-102
|
| Hearing Date |
11/19/2020 |
| Hearing Time |
08:45 AM |
| Hearing Location |
Webinar Only: https://attendee.gotowebinar.com/register/1806347380398817295 |
| Contact Name |
Elena M. Kemp |
| Contact Title |
Regulatory Coordinator |
| Contact Telephone |
303-894-7426 |
| Contact email |
dora_dpo_rulemaking@state.co.us |